Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/23/2000 | WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
11/23/2000 | WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders |
11/23/2000 | DE19923571A1 New plant promoter containing cis-acting elements, useful for producing transgenic plants with increased tolerance of pathogens, particularly fungi |
11/23/2000 | DE19923568A1 Incorporating gcpE and yfgB genes into viruses and cells, for increasing isoprenoid content and identifying e.g. antimicrobial agents, comprises using DNA sequences from bacteria or parasites |
11/23/2000 | DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers |
11/23/2000 | DE19919124A1 Nukleinsäuremolekül, umfassend eine für ein Polypeptid mit Chorismatmutase-Aktivität kodierende Nukleinsäure Nucleic acid molecule comprising a sequence encoding a polypeptide having chorismate mutase activity nucleic acid |
11/23/2000 | DE19918949A1 Überexpression einer DNA-Sequenz codierend für eine 1-Desoxy-D-Xylulose-5-Phosphat Reduktoisomerase in Pflanzen Over-expression of a DNA sequence encoding a 1-deoxy-D-xylulose-5-phosphate reductoisomerase in plants |
11/23/2000 | DE19918446A1 Verwendung von Coxsackievirus B3 zur Verbesserung der Transfektion von Zellen Use of coxsackievirus B3 to improve the transfection of cells |
11/23/2000 | DE10024247A1 Sample holder for biological analyses comprises different specific binding substances arranged on different layers of a substrate |
11/23/2000 | CA2376722A1 Chloramphenicol biosynthetic pathway and gene cluster characterization |
11/23/2000 | CA2374272A1 Promoter of thioredoxine tatrxh2 in wheat |
11/23/2000 | CA2374235A1 Production of complex carbohydrates |
11/23/2000 | CA2374053A1 Secreted polypeptides and corresponding polynucleotides |
11/23/2000 | CA2374045A1 Compositions isolated from skin cells and methods for their use |
11/23/2000 | CA2374015A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme |
11/23/2000 | CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
11/23/2000 | CA2373616A1 Tm4sf receptors |
11/23/2000 | CA2373243A1 Automated nucleic acid compaction device |
11/23/2000 | CA2373231A1 Extracellular signaling molecules |
11/23/2000 | CA2373191A1 Full-length molecules expressed in human tissues |
11/23/2000 | CA2372926A1 143 human secreted proteins |
11/23/2000 | CA2372783A1 Identifying material from a breast duct |
11/23/2000 | CA2372667A1 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus |
11/23/2000 | CA2372654A1 Acquired resistance genes in plants |
11/23/2000 | CA2372582A1 Novel fab fragment libraries and methods for their use |
11/23/2000 | CA2372556A1 Directed evolution of microorganisms |
11/23/2000 | CA2372549A1 Ox2 receptor homologs |
11/23/2000 | CA2372541A1 Sphingosine kinase enzyme |
11/23/2000 | CA2372534A1 Differentiated human embryoid cells and a method for producing them |
11/23/2000 | CA2372485A1 Cell concentration and lysate clearance using paramagnetic particles |
11/23/2000 | CA2372435A1 Recombinant human mannan-binding lectin |
11/23/2000 | CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes |
11/23/2000 | CA2372323A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
11/23/2000 | CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
11/23/2000 | CA2372200A1 Self-assembling biomolecular structures |
11/23/2000 | CA2372198A1 Protein scaffold and its use to multimerise monomeric polypeptides |
11/23/2000 | CA2372163A1 A method and relational database management system for storing, comparing, and displaying results produced by analyses of gene array data |
11/23/2000 | CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
11/23/2000 | CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily |
11/23/2000 | CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
11/23/2000 | CA2372054A1 Ph dependent ion exchange matrix and method of use in the isolation of nucleic acids |
11/23/2000 | CA2372036A1 Compositions of solvents and high concentrations of nucleic acid analogs |
11/23/2000 | CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
11/23/2000 | CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects |
11/23/2000 | CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
11/23/2000 | CA2368948A1 Envelope gene-deficient virus vector of paramyxoviridae |
11/23/2000 | CA2368833A1 Molecules expressed in hippocampus |
11/23/2000 | CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
11/22/2000 | EP1054064A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
11/22/2000 | EP1054063A2 Process for the production of naturally folded and secreted proteins |
11/22/2000 | EP1054062A1 Glycosyltransferase and dna encoding the same |
11/22/2000 | EP1054061A1 Protein standard, comprising at least one antibody-binding domain of streptococcal protein G |
11/22/2000 | EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation |
11/22/2000 | EP1054058A1 Pharmaceutical composition for treatment of Duchenne muscular dystrophy |
11/22/2000 | EP1054057A1 Mutagenesis method |
11/22/2000 | EP1054056A1 Apparatus for immobilized dna library preparation, apparatus for gene amplification, method for temperature control and method for comparing genes systematically |
11/22/2000 | EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents |
11/22/2000 | EP1054018A1 Fab fragment libraries and methods for their use |
11/22/2000 | EP1053677A1 Nonhuman animal embryonic stem cells and nonhuman animals having variant smooth muscle myosin heavy-chain genes |
11/22/2000 | EP1053460A2 An automatic method of classifying molecules |
11/22/2000 | EP1053357A1 Processes for isolating, amplifying and characterizing dna |
11/22/2000 | EP1053356A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
11/22/2000 | EP1053353A1 Eluting reagents, methods and kits for isolating dna |
11/22/2000 | EP1053352A1 Mismatch detection techniques |
11/22/2000 | EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor |
11/22/2000 | EP1053350A1 Methods for dna amplification and sequencing |
11/22/2000 | EP1053349A1 Methods for identifying therapeutic targets |
11/22/2000 | EP1053347A1 Peptide detection method |
11/22/2000 | EP1053343A2 Targeting of genetic vaccine vectors |
11/22/2000 | EP1053342A2 Nucleic acid delivery vehicles |
11/22/2000 | EP1053341A1 Use of negative regulation elements for nerve-specific expression of transgenes |
11/22/2000 | EP1053340A1 Genetic manipulation of spermatogonia |
11/22/2000 | EP1053339A1 Nucleotide sequences encoding maize rad51 |
11/22/2000 | EP1053338A1 Alteration of amino acid compositions in seeds |
11/22/2000 | EP1053337A1 Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase |
11/22/2000 | EP1053336A1 Promoter inductible in plants, sequence incorporating same and resulting product |
11/22/2000 | EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
11/22/2000 | EP1053334A1 Plant alkaline and neutral invertases |
11/22/2000 | EP1053333A1 Single-chain polypeptides comprising creatine kinase m and creatine kinase b |
11/22/2000 | EP1053332A1 Protein |
11/22/2000 | EP1053331A2 A novel fungal protein critical for expression of fungal proteins |
11/22/2000 | EP1053330A2 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
11/22/2000 | EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE |
11/22/2000 | EP1053328A2 Plant having altered environmental stress tolerance |
11/22/2000 | EP1053327A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof |
11/22/2000 | EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
11/22/2000 | EP1053324A1 Novel cystine knot protein and materials and methods for making it |
11/22/2000 | EP1053323A2 Human receptor proteins |
11/22/2000 | EP1053322A1 Wnt-10a |
11/22/2000 | EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
11/22/2000 | EP1053320A2 Human transport-associated molecules |
11/22/2000 | EP1053319A2 Human genes and gene expression products ii |
11/22/2000 | EP1053318A2 Cdnas encoding secreted proteins |
11/22/2000 | EP1053317A1 Use of ribozymes for functionating genes |
11/22/2000 | EP1053316A1 Nucleic acids provided for modulating cellular activation |
11/22/2000 | EP1053313A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences |
11/22/2000 | EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines |
11/22/2000 | EP1053311A2 Compositions and methods for using a lysing matrix for isolating dna |